The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Chlamydia trachomatis Persistence In Vitro: An Overview
Open accessAbstract
Chlamydiae growing in target mucosal human epithelial cells in vitro can transition from their normal developmental cycle progression, alternating between infectious but metabolically inactive elementary bodies to metabolically active but noninfectious reticulate bodies (RBs) and back to elementary bodies, into a state of persistence. Persistence in vitro is defined as viable but noncultivable chlamydiae involving morphologically enlarged, aberrant, and nondividing RBs. The condition is reversible, yielding infectious elementary bodies after removal of the inducers, including penicillin, interferon-gamma, iron or nutrient starvation, concomitant herpes infection, or maturation of the host cell into its physiologically differentiated state. All aberrant RB phenotypes are not the same, owing to differing up- or down-regulated chlamydial gene sets and subsequent host responses. Although all persistence-inducing conditions exist in vivo, key questions include (1) whether or not aberrant chlamydial RBs occur in vivo during the alternating acute-silent chronic-acute chlamydial infection scenario that exists in infected patients and animals and (2) whether such aberrant RBs can contribute to prolonged, chronic inflammation, fibrosis, and scarring.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The chlamydial developmental cycle: Figure 1
AbdelRahman, Y. M., & Belland, R. J. (2005) · FEMS Microbiology Reviews · doi:10.1016/j.femsre.2005.03.002 · Cited by 631
Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis
Beatty, W. L., Morrison, R., & Byrne, G. I. (1994) · Microbiological Reviews · doi:10.1128/mmbr.58.4.686-699.1994 · Cited by 588
Genomic transcriptional profiling of the developmental cycle of Chlamydia trachomatis
Belland, R. J., Zhong, G., Crane, D. D., Hogan, D., Sturdevant, D., Sharma, J., Beatty, W. L., & Caldwell, H. D. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1331135100 · Cited by 500
Beatty, W. L., Byrne, G. I., & Morrison, R. P. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.9.3998 · Cited by 466
Chlamydial Persistence: beyond the Biphasic Paradigm
Hogan, R. J., Mathews, S. A., Mukhopadhyay, S., Summersgill, J. T., & Timms, P. (2004) · Infection and Immunity · doi:10.1128/iai.72.4.1843-1855.2004 · Cited by 461
Byrne, G. I., Lehmann, L. K., & Landry, G. J. (1986) · Infection and Immunity · doi:10.1128/iai.53.2.347-351.1986 · Cited by 385
Pathogenesis of Genital Tract Disease Due to Chlamydia trachomatis
Darville, T., & Hiltke, T. J. (2010) · The Journal of Infectious Diseases · doi:10.1086/652397 · Cited by 334
Caldwell, H. D., Wood, H., Crane, D., Bailey, R., Jones, R. B., Mabey, D., Maclean, I., Mohammed, Z., Peeling, R., Roshick, C., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17993 · Cited by 310
Chlamydia pneumoniae Infection in Circulating Human Monocytes Is Refractory to Antibiotic Treatment
Gieffers, J., Füllgraf, H., Jahn, J., Klinger, M., Dalhoff, K., Katus, H. A., Solbach, W., & Maass, M. (2001) · Circulation · doi:10.1161/01.cir.103.3.351 · Cited by 248
Matsumoto, A., & Manire, G. P. (1970) · Journal of Bacteriology · doi:10.1128/jb.101.1.278-285.1970 · Cited by 220
Raulston, J. E. (1997) · Infection and Immunity · doi:10.1128/iai.65.11.4539-4547.1997 · Cited by 177
Chlamydia trachomatis infection and pregnancy outcome
Sweet, R., Landers, D., Walker, C., & Schachter, J. (1988) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(88)90309-8 · Cited by 172
COLES, A. M., Reynolds, D. J., Harper, A., Devitt, A., & Pearce, J. H. (1993) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1993.tb05958.x · Cited by 121
Chlamydial infection. Role of Chlamydia subgroup A in non-gonococcal and post-gonococcal urethritis.
Richmond, S., Hilton, A. L., & Clarke, S. K. R. (1972) · Sexually Transmitted Infections · doi:10.1136/sti.48.6.437 · Cited by 114
Ouellette, S. P., Hatch, T. P., AbdelRahman, Y. M., Rose, L. A., Belland, R. J., & Byrne, G. I. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05465.x · Cited by 108
Ultrastructural and molecular analyses of the persistence of (serovar K) in human monocytes
Koehler, L., Nettelnbreker, E., Hudson, A. P., Ott, N., Gérard, H. C., Branigan, P. J., Schumacher, H. R., Drommer, W., & Zeidler, H. K. (1997) · Microbial Pathogenesis · doi:10.1006/mpat.1996.0103 · Cited by 106
Protective Immunity to Chlamydial Genital Infection: Evidence from Animal Studies
Rank, R. G., & Whittum‐Hudson, J. A. (2010) · The Journal of Infectious Diseases · doi:10.1086/652399 · Cited by 98
Gérard, H. C., Krauße‐Opatz, B., Wang, Z., Rudy, D., Rao, J. P., Zeidler, H. K., Schumacher, H. R., Whittum‐Hudson, J. A., Köhler, L., & Hudson, A. P. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02550.x · Cited by 95
Mäurer, A. P., Mehlitz, A., Mollenkopf, H., & Meyer, T. F. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030083 · Cited by 92
Wyrick, P. B., & Knight, S. T. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh283 · Cited by 82
Self-citationKazár, J., Gillmore, J. D., & Gordon, F. B. (1971) · Infection and Immunity · doi:10.1128/iai.3.6.825-832.1971 · Cited by 60
Ficarra, M., Ibana, J. A., Porretta, C. P., Ma, L., Myers, L., Taylor, S. N., Greene, S. J., Smith, B., Hagensee, M., Martin, D. H., et al. (2008) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2008.00639.x · Cited by 59
Guseva, N. V., Knight, S. T., Whittimore, J. D., & Wyrick, P. B. (2003) · Infection and Immunity · doi:10.1128/iai.71.8.4700-4710.2003 · Cited by 57
Self-citationRothermel, C. D., Rubin, B. Y., Jaffe, E. A., & Murray, H. W. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.2.689 · Cited by 53
Rank, R. G., Sanders, M. M., & Kidd, A. T. (1993) · PubMed · Cited by 48
Cytotoxic-T-lymphocyte-mediated cytolysis of L cells persistently infected with Chlamydia spp
Rasmussen, S. J., Timms, P., Beatty, P. R., & Stephens, R. S. (1996) · Infection and Immunity · doi:10.1128/iai.64.6.1944-1949.1996 · Cited by 31
Cited by
Sexually Transmitted Infections Treatment Guidelines, 2021
Workowski, K. A., Bachmann, L. H., Chan, P. A., Johnston, C. M., Muzny, C. A., Park, I., Reno, H., Zenilman, J. M., & Bolan, G. A. (2021) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7004a1 · Cited by 3,018
Sexually Transmitted Diseases Treatment Guidelines, 2010
(2011) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2011.04.006 · Cited by 2,076
Sexually transmitted infections: challenges ahead
Unemo, M., Bradshaw, C. S., Hocking, J. S., de Vries, H. J. C., Francis, S. C., Mabey, D., Marrazzo, J. M., Sonder, G. J. B., Schwebke, J. R., Hoornenborg, E., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30310-9 · Cited by 751
Effects of Mentha suaveolens Essential Oil on Chlamydia trachomatis
Sessa, R., Di Pietro, M., De Santis, F., Filardo, S., Ragno, R., & Angiolella, L. (2015) · BioMed Research International · doi:10.1155/2015/508071 · Cited by 470
(2019) · doi:10.7554/elife.42295 · Cited by 31
Metadata
- Authors
- Wyrick, P. B.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-06-15
- Volume
- 201
- Issue
- S2
- Pages
- 88-95
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2145528532
- Cited by
- 257
- References
- 27
- FWCI
- 12.45
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.